AstraZeneca caught a break, and then it didn’t, but what about AEFI?

By Nithin Sasikumar in BFO #259, 08 Apr, 21

On 18 March, the head of the European Medicines Agency (EMA), the EU’s drug regulator, announced in a press conference that the Covid-19 shot developed by AstraZeneca and Oxford University was not associated with unusual blood clots reported by vaccine recipients in some countries. 

On 6 April, the World Health Organization (WHO) put its weight behind the vaccine as well, saying that the benefits far outweigh the risks.